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Abstract
Background: Bacterial Infections involving multi-drug resistant (MDR) phenotypes constitute a worldwide health
concern. The present work was designed to assess the antibacterial properties of the methanol extracts of six
medicinal plants (Anthocleista schweinfurthii, Nauclea latifolia, Boehmeria platyphylla, Caucalis melanantha, Erigeron
floribundus and Zehneria scobra) and the effects of their associations with antibiotics on MDR Gram-negative
bacteria over-expressing active efflux pumps.
Methods: The antibacterial activities and the ability to potentiate antibiotic effects of the methanol extracts the
tested plants were evaluated in vitro against twenty eight Gram-negative bacteria expressing MDR phenotypes,
using broth microdilution method. The phytochemical screening of these extracts was also performed using
standard methods.
Results: All tested extracts displayed moderate to low antibacterial activity on at least 14.3 % of the 28 tested
bacteria, with MIC values ranged from 128 to 1024 μg/mL. The best antibacterial spectrum was observed with
Naulcea latifolia bark extract. Extracts from A. schweinfurthii fruits, N. latifolia stem bark, Z. scobra and N. latifolia
leaves showed synergistic effects with many antibiotics against MDR bacteria.
Conclusion: The overall results of the present study provide information for the possible use of the studied plants,
especially Nauclea latifolia in the control of Gram-negative bacterial infections including MDR species as
antibacterials as well as resistance modulators.
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Background
Infectious diseases still represent one of the major health
concern worldwide [1]. According to the National Insti-
tute of Health, infectious diseases are the second cause
of death and the leading cause of loss of productive life
years worldwide. Bacterial infections are responsible of
about 70 % of cases of death related to microorganisms
[1]. The use of antibiotics and hygiene rules helped to
fight infectious diseases in the past. However, they are
becoming increasingly difficult to control as results of
the spread of resistant phenotypes. The resistance to an-
tibiotics has increased in recent decades, mainly due of
their inappropriate use [2]. Bacteria have developed sev-
eral mechanisms of resistance including active efflux
which plays an important role in multi-drug resistance
(MDR), mainly in Gram-negative bacteria [3]. There is a
need for the discovery of new active antimicrobials to
combat MDR microorganisms. Amongst the new areas
explored to overcome infectious diseases caused by
MDR bacteria, medicinal plants seem to offer an ideal
alternative since they are readily available source of bio-
active agents and are well accepted by about 80 % of the
world population. Many African medicinal plants and
their metabolites were previously found active against
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Table 1 General informations and report on evidence of biological activities and chemistry of the studied plants
Species (family);
Voucher number*
Traditional uses Parts used traditionally Area of plant
collection





Hernia, female sterility, stomach-ache
in women, ovarian problems, venereal
diseases, bronchitis, fever, purgative,
malaria, hard abscesses anthelminthic,
otitis, ophthalmia, pain, malaria, cancers,
venereal diseases, bacterial diseases [21]
Stem bark, roots, Sap




Polyphenols, alkaloids, terpenes and
steroids [21], schweinfurthiin 1,
bauerenone 2, bauerenol 3, 1-hydroxy-3,7,8
trimethoxy-xanthone 4 and 1,
8-dihydroxy-3, 7 dimethoxy-xanthone 5 [35]
Antibacterial activity against
Staphylococcus





Stomachic [36] and dysentery [37],
control bleeding [28], skin burns


























Skin disorders [32], Acquired
immunodefiency syndrome (AIDS)
therapy [41], antipyretic, and
anti-inflammatory [42], gastrointestinal
tract infections




phenols, alkaloids and essential oils [42],
Phenolics, olean-3-oleil-12,18 diene [43].
Analgesic and antiinflammatory [42];
antifungal activity against Epidermophyton
floccosum, Microsporum canis, M. gypseum,
M. langeronii, Trichophyton mentagrophytes,






Gonorrhea [45], hypertension [46],
gastrointestinal tract disorders [47],
prolong menstrual flow [48]. stomach







Naucleamides A,B,C,D,E [50] antimicrobial activity of methanol extract
against E. coli, S. dysenteriae, S. aureus, Bacillus





Fever, diarrhea, skin diseases, stomach





Gypenoside [51] Antimicrobial activity of ethanol extract
against E-coli, Pseudomonas auruginosa,
S. aureus, E. coli [51], Vibrio cholerae,
Enterobacter aerogenes, Klebsiella pneumoniae,
Salmonella paratyphi, Proteus mirabilis, Proteus






















MDR Gram-negative bacteria [4, 5]. Also the synergistic
activities of some African medicinal plants with antibi-
otics against MDR Gram-negative bacteria were reported
[5, 6]. It was demonstrated that several naturally occur-
ring efflux pump inhibitors can restore the activity of an-
tibiotics against MDR bacteria [7, 8]. The present study
was therefore designed to investigate the antibacterial
potential against MDR Gram-negative phenotypes ex-
pressing active efflux pumps of six Cameroonian me-
dicinal plants used traditionally in the treatment of
bacterial infections, namely Anthocleista schwein-
furthii Gilg.(Loganiaceae), Boehmeria platyphylla D.
Don (Urticaceae), Caucalis melanantha (Hochst/Hien)
(Urticaceae), Erigeron floribundus (H.BK) (Asteraceae),
Nauclea latifolia Smith (Rubiaceae) and Zehneria
scobra (cf ) Sondev (Cucurbitaceae).
Methods
Plant materials and extraction
The plant materials used in this study were collected on
April 2013 in West and South West regions of
Cameroon and identified by a specialist of the National
Herbarium (Table 1). The plants included two trees
namely Anthocleista schweinfurthii and Nauclea latifo-
lia, and four herbs namely Boehmeria platyphylla,
Caucalis melanantha, Erigeron floribundus and Zeh-
neria scobra. The whole plant was collected for herbs
whilst leaves, fruits and stem bark were collected for
trees. Each plant material was dried at room
temperature and powdered using a grinder. One hun-
dred grams of each powder was then macerated in 1 L
of pure methanol (MeOH) for 48 h and filtered
through Whatman filter paper no.1. The filtrate ob-
tained was concentrated under reduced pressure in a
rotary evaporator to obtain the crude extract. All crude
extracts were then kept at 4 °C until further uses.
Phytochemical screening
The major phytochemical classes such as phenols tan-
nins, flavonoids, saponins, alkaloids, anthraquinones,
cardiac glycosides, steroids and triterpenes (Table 2)
were investigated according to the common described
phytochemical methods [9–13].
Chemicals for antibacterial assays
Seven commonly used antibiotics including tetracycline
(TET), kanamycin (KAN), streptomycin (STR), ciprofloxa-
cin (CIP), norfloxacin (NOR), chloramphenicol (CHL),
ampicillin (AMP), erythromycin (ERY) (Sigma-Aldrich, St
Quentin Fallavier, France) were used. p-Iodonitrotetrazo-
lium chloride 0.2 % (INT) and phenylalanine arginine
β-naphthylamide (PAβN) (Sigma-Aldrich) were used as
bacterial growth indicator and efflux pumps inhibitor
respectively.
Microorganisms and growth conditions
Pathogenic microorganisms used in the present study were
Gram-negative bacteria including MDR isolates (Laboratory
collection) and reference strains (American Type Culture
Collection) of Escherichia coli (ATCC8739, ATCC10536,
AG100, AG100A, AG100ATet, AG102, MC4100 W3110),
Enterobacter aerogenes (ATCC13048, CM64, EA27, EA289,
EA298, EA294), Klebsiella pneumoniae (ATCC11296,
KP55, KP63, K24, K2), Enterobacter cloacae (ECCI69,
BM47, BM67), Pseudomonas aeruginosa (PA01, PA124)
and Providencia stuartii (ATCC29916, NEA16, PS2636,
PS299645). The clinical strains were the laboratory collec-
tion from UMR-MD1, University of Marseille, France.
Their features are reported in Additional file 1: Table S1.
They were maintained at 4 °C and sub-cultured on a
fresh appropriate Mueller Hinton Agar (MHA) for 24 h
before any antibacterial test.
Table 2 Preliminary chemical composition of the studied plant extracts
Plant Part used* Phenols Tannins Flavonoids Saponins Alkaloids Anthraquinones Cardiac glycosides Steroids Triterpenes
A. melanantha W + + + - - + + - -
A. Schweinfurthii B + + - - - + + - +
F + + - - - + + - +
L + + - - - - + - -
B. platyphylla W + + - - - + + - -
E. floribundus W + + - - - - + - -
N. latifolia B + + - - - + + + +
F + + - - - + + - +
L + + - - - + + + +
Z. scobra W + - - - + - + - -
Extract were from [B stem bark, F fruits, L leaves, W whole plant]. (+): Present; (-): Absent
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Antibacterial assays
The MICs of the tested extracts were determined using
a rapid INT colorimetric assay [14]. Briefly, test samples
were first dissolved in dimethylsulfoxide/ Mueller Hinton
Broth (DMSO/MHB). The solution obtained was then
added to MHB and serially diluted two fold (in a 96-well
microtilter plate). One hundred microliters of inoculums
(1.5× 106 CFU/ml) prepared in MHB were then added.
The plates were covered, agitated with a shaker to mix the
contents of the wells and incubated at 37 °C for 18 h. The
final concentration of DMSO was 2.5 %, a concentration
at which DMSO does not affect bacterial growth. Wells
containing MHB, 100 μl of inoculum, and DMSO at a
final concentration of 2.5 % served as the negative control.
Chloramphenicol was used as reference antibiotic. The
MICs of each extract were detected after 18 h of incuba-
tion at 37 °C after addition of 40 μl INT (0.2 mg/ml) and
incubation at 37 °C for 30 min. Viable bacteria reduce
INT with appearance of a pink dye. The MIC of each sam-
ple was defined as its lowest concentration that prevented
this change and resulted in the complete inhibition of mi-
crobial growth. The Minimum Bactericidal Concentration
(MBC) was determined by sub-culturing samples from the
wells with concentrations above or equal to the MIC on
new plates of Mueller Hinton broth (MHB). The MBC
was considered as the lowest concentration of the ex-
tract which prevented appearance of pink color after
addition of INT. Each assay was performed in triplicate
at three different days.
Antibiotic-modulation assay
To evaluate the antibiotic resistance modifying activity
of the extracts, the MIC of antibiotics were determined
in the presence or absence of the plant extracts using
the broth microdilution technique as described above.
After a preliminary assay on two MDR bacteria, P. aeru-
ginosa PA124 and E. aerogenes CM64 (Additional file 1:
Tables S3 and S4), extracts from A. Schweinfurthii fruits,
N. Latifolia leaves and stem bark, and from the whole
plant of Z. scobra were selected and tested at their MIC/
2 and MIC/5 in combination with seven antibiotics
(CHL, AMP, KAN, NOR, ERY, TET and STR) on six
MDR bacterial strains (P. aeruginosa PA124, E. aerogenes
Table 3 Effect of sub-inhibitory concentrations of Anthocleista schweinfurthii fruits extract on the activities of first line antibiotics




Bacterial strains and MIC values (μg/mL) PBSS (%)
K. pneumoniae K24 P. stuartii NAE16 E. coli AG100 E. aerogenes EA289 P. aeruginosa PA124 E. aerogenes CM64
TET 0 64 64 16 8 16 32 -
MIC/2 64 64(1)I 8(2)S 8(1)I 64(0.25) A 16(2)S 33.33
MIC /5 64 64(1)I 8(2)S 8(1)I 64(0.25)A 16(2)S 33.33
NOR 0 ≥64 1 ≤0.25 - 128 2(1)I -
MIC/2 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
MIC/5 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
STR 0 2 32 ≥256 64 64 16 -
MIC/2 2(1)I 16(2)S ≥256 8(8)S 32(2)S 16(1)I 50
MIC/5 2(1)I 32(1)I ≥256 8(8)S 32(2)S 16(1)I 33.33
KAN 0 8 8 8 32 64 ≤2 -
MIC/2 8(1)I 8(1)I 2(4)S 2(16)S 32(2)S ≤2 50
MIC/5 8(1)I 8(1)I 4(2)S 2(16)S 32(2)S ≤2 50
CHL 0 16 8 8 512 64 512 -
MIC/2 8(2)S (2)S 8(1)I 256(2)S 64(1)I 256(2)S 66.67
MIC/5 8(2)S (2)S 8(1)I 512(1)I 64(1)I 256(2)S 50
ERY 0 128 16(1)I 64 128 128 256 -
MIC/2 64(2)S 16(1)I 64(1)I 128(1)I 128(1)I 128(2)S 33.33
MIC/5 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 128(2)S 16.67
AMP 0 - - 128 - - - -
MIC/2 - - 32(4)S - - - 16.67
MIC/5 - - 128(1)I - - - 0
(-) : >256 μg/ml; (): fold decrease in MIC values of the antibiotics after association with plants extract; S: Synergy, I: Indifference, A: antagonism, Antibotics (CHL
chloramphenicol, AMP ampicillin, KAN kanamycin, NOR norfloxacin, ERY erythromycin, TET tetracycline, STR streptomycin); PBSS percentage of bacteria strain on
which synergism has been observed
Djeussi et al. BMC Complementary and Alternative Medicine  (2016) 16:124 Page 4 of 9
EA289 and CM64, E. coli AG100, P. stuartii NAE16 and
K. pneumoniae K24).
The reverse of Fractional Inhibitory concentration (1/
FIC) was calculated as follows:
1=FIC ¼ MICAntibiotic alone=MICAntibiotic in combination with
The interpretation was made as follows: Synergistic (≥2),
Indifferent (1 to 0.5), or Antagonistic (≤0.25) [5, 15]. All
assays were performed in triplicate and repeated thrice.
Results
Phytochemical composition of the tested extracts
The main classes of secondary metabolites for each ex-
tract were screened and the results are summarized in
Table 2. It appears that all the plant extracts of this study
possess at least 3 classes of screened secondary metabo-
lites. Only three classes of the screened phytochemicals
were detected in the extracts from Z. scobra, E. floribun-
dus and A. schweinfurthii leaves. Extracts from N. latifo-
lia leaves and stem bark contained six phytochemical
classes. All the extracts contained phenols and cardiac
Glycosides.
Antibacterial activity
The results (Additional file 1: Table S2) showed that all
extracts displayed antibacterial activity against at least 4/
28 (14.3 %) tested bacterial strains, with MIC values
ranged from 128 to 1024 μg/mL. Extracts from A.
schweinfurthii leaves, fruits and bark exerted inhibitory
effects respectively against 14/28 (50 %), 13/28 (46.4 %)
and 8/28 (28.6 %) studied bacteria. The extracts from
the fruits and leaves of N. latifolia were active respect-
ively on 6/28 (21.4 %) and 7/28 (25 %) tested bacteria
whilst the bark extract displayed the best spectrum of
activity [active on 22/28 (78.6 %) tested bacteria]. Ex-
tracts of B. platyphylla and Erigeron floribundus also
showed large spectra of antibacterial activity with MIC
values recorded on 17/28 (60.7 %) and 21/28 (75 %) bac-
terial strains respectively. Causalis melanantha and Z.
scobra extracts displayed low antibacterial spectra [MIC
recorded respectively on 4/28 (14.3 %) and 7/28 (25 %)
tested bacterial]. P. aeuginosa PA124 appeared to be the





Bacterial strains and MIC values (μg/mL) PBSS (%)
K. pneumoniae K24 P. stuartii NAE16 E. coli AG100 E. aerogenes EA289 P. aeruginosa PA124 E. aerogenes CM64
TET 0 64 64 16 8 16 32 -
MIC/2 64(1)I 64(1)I 8(2)S 8(1)I 16(1)I 16(2)S 33.33
MIC /5 64(1)I 64(1)I 16(1)I 8(1)I 16(1)I 16(2)S 16.67
NOR 0 ≥64 1 ≤0.25 - 128 2(1)I -
MIC/2 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
MIC /5 ≥64 1(1)I ≤0.25 - 128(1)I 2(1)I 0
STR 0 2 32 ≥256 64 64 16 -
MIC/2 2(1)I 32(1)I ≥256 32(2)S 64(1)I 8(2)S 16.67
MIC /5 2(1)I 32(1)I ≥256 64(1)I 64(1)I 16(1)I 0
KAN 0 8 8 8 32 64 ≤2 -
MIC/2 8(1)I 8(1)I 4(2)S 16(2)S 64(1)I ≤2 33.33
MIC /5 8(1)I 8(1)I 8(1)I 32(1)I 64(1)I ≤2 16.67
CHL 0 16 8 8 512 64 512 -
MIC/2 16(1)I 4(2)S 8(1)I 512(1)I 64(1)I 512 16.67
MIC /5 16(1)I 8(1)I 8(1)I 512(1)I 64(1)I 512 0
ERY 0 128 16(1)I 64 128 128 256 -
MIC/2 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 128(2)S 16.67
MIC /5 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 256(1)I 0
AMP 0 - - 128 - - - -
MIC/2 - - 256(2)I - - - 0
MIC /5 - - 256(2)I - - - 0
(-) : >256 μg/ml; (): fold decrease in MIC values of the antibiotics after association with plants extract; S: Synergy, I: Indifference; A: antagonism, Antibotics (CHL
chloramphenicol, AMP ampicillin, KAN kanamycin, NOR norfloxacin, ERY erythromycin, TET tetracycline, STR streptomycin); PBSS percentage of bacteria strain on
which synergism has been observed
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most resistant bacteria strain with the sensitivity ob-
served only towards N. latifolia bark extract.
Antibiotic resistance modifying activities of the plant
extracts
Preliminary results obtained in two most resistant
strains, P. aeruginosa PA124 and E. aerogenes CM64 (re-
sults presented in Additional file 1: Tables S3 and S4)
allowed selecting the following extracts: A. schwein-
furthii fruits, N. latifolia leaves and bark and Z. scobra
as well as the appropriate sub-inhibitory concentrations
of MIC/2 and MIC/5 for further studies. From the re-
sults summarised in Tables 3, 5, 5 and 6, it appears that
all the four extracts improved the activities of antibiotics,
from 2 to more than 64 folds. The highest activities were
observed with A. schweinfurthii fruits (Table 3) and Z.
scobra (Table 6). A. schweinfurthii fruits potentiated the
activities of TET on 66.7 % and 50 % of the bacteria
strains at MIC/2 and MIC/5 respectively. It also in-
creased the activity of KAN (MIC/2 and MIC/5) and
STR (MIC/2) in 50 % of the tested bacterial strains while
Z. scobra improved the activities of STR on 66.7 % and
50 % of the bacteria strains at MIC/2 and MIC/5 re-
spectively. Z. scobra also improved the activity of CHL
on 50 % of the tested bacterial strains at the two sub-
inhibitory concentrations of MIC/2 and MIC/5 (Table 6).
Synergistic effects (50 % of antibiotic activity potentiat-
ing at MIC/2 and MIC/5) were observed with N. Latifo-
lia leaves extract (Table 5) on TET and STR. The
highest rate of improvement of antibiotic activity by N.
Latifolia stem bark extract was rather noticed on TET
and KAN with a rate of 33.3 %. Among the four extracts,
this later displayed the lowest antibiotic potentiating ef-
fect. Moreover, no synergistic effect was observed with
NOR, while synergy between the studied extracts and
antibiotics were observed with Ampicilin, with a rate of
only 16.67 % (Table 5).
Discussion
Medicinal plants are potential source of antimicrobial
agents used in the treatment of infectious diseases [16].
According to Rios and Recio [17], and Kuete et al. [17],
the antibacterial activity of a plant extract is considered
significant when the MICs are below 100 μg/mL. The





Bacterial strains and MIC values (μg/mL) PBSS
(%)K. pneumoniae K24 P. stuartii NAE16 E. coli AG100 E. aerogenes EA289 P. aeruginosa PA124 E. aerogenes CM64
TET 0 64 64 16 8 16 32 -
MIC/2 64(1)I 32(2)S 8(2)S 2(4)S 16(1)I 32(1)I 50.00
MIC /5 64(1)I 32(2)S 8(2)S 4(2)S 16(1)I 32(1)I 50.00
NOR 0 ≥64 1 ≤0.25 - 128 2(1)I -
MIC/2 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
MIC /5 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
STR 0 2 32 ≥256 64 64 16 -
MIC/2 2(1)I 16(2)S 32(≥8)S 16(4)S 64(1)I 2(8)S 50.00
MIC /5 2(1)I 32(1)I 32(≥8)S 32(2)S 64(1)I 8(2)S 50.00
KAN 0 8 8 8 32 64 ≤2
MIC/2 8(1)I 8(1)I 2(4)S 16(2)S 64(1)I ≤2 33.33
MIC /5 8(1)I 8(1)I 4(2)S 32(1)I 64(1)I ≤2 16.67
CHL 0 16 8 8 512 64 512 -
MIC/2 16(1)I 4(2)S 8(1)I 256(2)S 64(1)I 512 33.33
MIC /5 16(1)I 4(2)S 8(1)I 256(2)S 64(1)I 512 33.33
ERY 0 128 16(1)I 64 128 128 256 -
MIC/2 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 256(1)I 0
MIC /5 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 256(1)I 0
AMP 0 - - 128 - - - -
MIC/2 - - 64(2)S - - - 16.67
MIC /5 - - 128(1)I - - - 0
(-) : >256 μg/ml; (): fold decrease in MIC values of the antibiotics after association with plants extract; S: Synergy, I: Indifference; A: antagonism, Antibotics (CHL
chloramphenicol, AMP ampicillin, KAN kanamycin, NOR norfloxacin, ERY erythromycin, TET tetracycline, STR streptomycin); PBSS percentage of bacteria strain on
which synergism has been observed
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activity is considered moderate when 100 ≤MIC ≤
625 μg/mL and weak when MIC are above 625 μg/mL
[17]. Therefore, the antibacterial activities reported in
the present study can mostly be regarded as moderate or
low. This could be explained by the fact that the tested
bacteria are mostly MDR phenotypes. In fact, P. aerugi-
nosa and MDR Enterobacteriaceae ( K. pneumoniae, E.
aerogenes, E.cloacae and P. stuartii and E. coli) tested in
the present study have been classified as antimicrobial-
resistant organisms of concern in healthcare facilities
[18–20]. The previously reported activities of A. schwein-
furthii include antibacterial inhibitory effects of n-hexane,
dichloromethane, ethyl acetate and methanol extracts
from leaves and stem bark against Staphylococcus aureus
ATCC 33591 and E. coli ATCC 27195 [21]. The MIC
values obtained in the present study were respectively 62.5
and 125 μg/ml against S. aureus and E. coli. Such values
were higher than those previously documented, highlight-
ing the MDR feature of the studied bacteria. MBC values
were obtained in few cases (Additional file 1: Table S2). A
keen look of data (Additional file 1: Table S2) indicates
that, in most of the cases, the tested extract exerted
bacteriostatic effects with a ratio MBC/MIC above 4. The
overall antibacterial activity of the tested extracts could be
due their phytochemical composition. However, the pres-
ence of a specific class of second metabolite could not
guarantee the antibacterial activity of the plant, as this will
depend on nature of the compounds, its concentration as
well as the possible interactions with other constituents of
the extract. It is also surprising that saponins, known to
possess antibacterial activities were not detected in the
tested extracts; However, this does means that the extract
were completely devoid of this class of secondary metab-
olite; One of the most understandable explanation should
that saponins could be present in very little amounts in
the tested extract, and therefore could not be detected
using the qualitative phytochemical methods. Some car-
diac glycosides such as bufalin, oubain, digoxin are toxic
meanwhile many of them have therapeutic uses and these
primarily involve the treatment of cardiac failure [22–24].
Their utility results from an increased cardiac outpout by
increasing the force of contraction. By increasing intracel-
lular calcium, cardiac glycosides increase calcium-induced
calcium release and thus contraction [23, 24]. The





Bacterial strains and MIC values (μg/mL) PBSS (%)
K. pneumoniae K24 P. stuartii NAE16 E. coli AG100 E. aerogenes EA289 P. aeruginosa PA124 E. aerogenes CM64
TET 0 64 64 16 8 16 32 -
MIC/2 64(1)I 64(1)I 8(2)S 8(1)I 16(1)I 32(1)I 16.67
MIC/5 64(1)I 64(1)I 8(2)S 8(1)I 16(1)I 32(1)I 16.67
NOR 0 ≥64 1 ≤0.25 - 128 2(1)I -
MIC/2 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
MIC/5 ≥64 1(1)I ≤0.25 - 128 (1)I 2(1)I 0
STR 0 2 32 ≥256 64 64 16 -
MIC/2 2(1)I 16(2)S ≥256 8(8)S 32(2)S 4(4)S 66.67
MIC/5 2(1)I 16(2)S ≥256 16(4)S 32(2)S 4(4)S 50
KAN 0 8 8 8 32 64 ≤2 -
MIC/2 8(1)I 8(1)I 4(2)S 4(8)S 64(1)I ≤2 33.33
MIC/5 8(1)I 8(1)I 8(1)I 8(4)S 64(1)I ≤2 16.67
CHL 0 16 8 8 512 64 512 -
MIC/2 8(2)S (2)S 8(1)I 512(1)I 64(1)I 256(2)S 50
MIC/5 8(2)S 8(1)I 8(1)I 512(1)I 64(1)I 256(2)S 50
ERY 0 128 16(1)I 64 128 128 256 -
MIC/2 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 128(2)S 16.67
MIC/5 128(1)I 16(1)I 64(1)I 128(1)I 128(1)I 256(1)I 0
AMP 0 - - 128 - - - -
MIC/2 - - 128(1)I - - - 0
MIC/5 - - 128(1)I - - - 0
(-) : >256 μg/ml; (): fold decrease in MIC values of the antibiotics after association with plants extract; S: Synergy. I: Indifference; A: antagonism. Antibotics (CHL
chloramphenicol, AMP ampicillin, KAN kanamycin, NOR norfloxacin, ERY erythromycin, TET tetracycline, STR streptomycin); PBSS percentage of bacteria strain on
which synergism has been observed
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traditional use of the studied plants could suggest that
their cardiac glycoside could be not toxic and have very
low toxic effects.
To the best of our knowledge, the present work de-
scribes for the first time the antibacterial activity of B.
platyphylla. This activity could be due to the presence of
the detected phytochemicals. In fact, antibacterial com-
pounds such as acetophenone [25] and cryptopleurine
[26–28] were previously isolated from B. Platyphylla.
The antibacterial activity of C. melanantha and E. flori-
bundus is also reported here for the first time. However
these plants were previously reported for their antifungal
activities [29–32]. The antibacterial activities of extracts
from Zehneria scobra and Nauclea latifolia [33, 34] were
reported on some bacteria: The present study therefore
provides additional information on the activity of these
plants against MDR Gram-negative phenotypes.
The synergistic effects between antibiotics and the
tested plants are also reported here for the first time.
The observed synergistic effects could be due to possible
interaction between plant constituents and the tested
antibiotics. As the strains used in this study are known
to actively expressed efflux pumps, one of the possible
explanations for the observed synergistic effects could
be the ability of the constituents of the extracts to act as
efflux pumps inhibitor. This can explain why the effect
of antibiotics with intracellular targets such as STR,
CHL and KAN increased contrary to that of beta-
lactamine (AMP) acting in the cell wall (Tables 3, 4, 5
and 6).
Conclusion
The overall results of the present study provides baseline
information for the possible use of the tested plants, es-
pecially A. schweinfurthii, N. Latifolia, B. platyphylla
and E. floribundus in the control of infections due to
Gram-negative bacteria. The present study indicates that
the tested plant extracts alone could not be used effi-
ciently to tackle MDR bacterial infections. However, it
was demonstrated that extracts from A. schweinfurthii
fruits and Z. scobra could be used in combination with
some antibiotics to fight bacterial multi-drug resistance.
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